Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry

// Maria-Magdalena Georgescu 1 , Adriana Olar 2 , Bret C. Mobley 3 , Phyllis L. Faust 4 and Jack M. Raisanen 5 1 Department of Pathology, Louisiana State University and Feist-Weiller Cancer Center, Shreveport, 71103, LA, USA 2 Department of Pathology and Laboratory Medicine and Neurosurgery, Medical University of South Carolina and Hollings Cancer Center, Charleston, 29425, SC, USA 3 Department of Pathology, Vanderbilt University Medical Center, Nashville, 37232, TN, USA 4 Department of Pathology and Cell Biology, Columbia University, New York, 10032, NY, USA 5 Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, 75390, TX, USA Correspondence to: Maria-Magdalena Georgescu, email: mmgeorgescu@yahoo.com Keywords: NHERF1/EBP50; chordoid meningioma; epithelial differentiation; microvilli; NF2 Received: November 27, 2017 Accepted: May 24, 2018 Published: June 19, 2018 ABSTRACT Meningioma is a primary brain tumor arising from the neoplastic transformation of meningothelial cells. Several histological variants of meningioma have been described. Here we show that NHERF1/EBP50, an adaptor protein required for structuring specialized polarized epithelia, can distinguish meningioma variants with epithelial differentiation. NHERF1 decorates the membrane of intracytoplasmic lumens and microlumens in the secretory variant, consistent with a previously described epithelial differentiation of this subtype. NHERF1 also labels microlumens in chordoid meningioma, an epithelial variant not previously known to harbor these structures, and ultrastructural analysis confirmed the presence of microlumens in this variant. NHERF1 associates with the ezrin-radixin-moesin (ERM)-NF2 cytoskeletal proteins, and moesin but not NF2 was detectable in the microlumens. In a meningioma series from 83 patients, NHERF1 revealed microlumens in 87.5% of the chordoid meningioma ( n = 25) and meningioma with chordoid component ( n = 7) cases, and in 100% of the secretory meningioma cases ( n = 12). The most common WHO grade I meningioma variants lacked microlumens. Interestingly, 20% and 66.6% of WHO grades II ( n = 20) and III ( n = 3) meningiomas, respectively, showed microlumen-like NHERF1 staining of ultrastructural tight microvillar interdigitations, mainly in rhabdoid, papillary-like or sheeting areas, revealing a new subset of high grade meningiomas with epithelial differentiation. NHERF1 failed to detect microlumens in 12 additional cases of chordoid glioma of the 3rd ventricle, chordoma and chondrosarcoma, neoplasms that may mimic the histological appearance of chordoid meningioma. This study uncovers features of epithelial differentiation in meningioma and proposes NHERF1 immunohistochemistry as a method of discriminating chordoid meningioma from neoplasms with similar appearance.